LIM
Leavell Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $865K | Buy |
17,777
+7,777
| +78% | +$378K | 0.04% | 323 |
|
|
2025
Q1 | $340K | Buy |
+10,000
| New | +$340K | 0.02% | 450 |
|
|
2024
Q4 | – | Sell |
-5,700
| Closed | -$268K | – | 541 |
|
|
2024
Q3 | $268K | Sell |
5,700
-6,950
| -55% | -$327K | 0.01% | 481 |
|
|
2024
Q2 | $683K | Buy |
12,650
+2,150
| +20% | +$116K | 0.04% | 316 |
|
|
2024
Q1 | $716K | Hold |
10,500
| – | – | 0.04% | 305 |
|
|
2023
Q4 | $657K | Buy |
10,500
+4,400
| +72% | +$275K | 0.04% | 300 |
|
|
2023
Q3 | $277K | Buy |
+6,100
| New | +$277K | 0.02% | 402 |
|